Who Paid My Doc
Thomas Lovely
Neurological Surgery Latham, NY Medical Doctor
NPI 1114982105 CMS profile 322524
1182 Troy Schenectady Rd Suite 100, St. Peter's Hospital Spine And Neurosurgery, Latham, NY 12110
General payments
$11,106
Research payments
$2,194
Ownership & investment interest
$0
Research they led as principal investigator
$1,788
Through program year 2025, Thomas Lovely of Latham, NY is reported in the CMS Open Payments database as having received $11,106 across 48 general payments and $2,194 in research payments paid to them. Separately, studies naming them as principal investigator received $1,788 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 73rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $6,013 | 10 | |
| 2024 | General | $2,113 | 3 | |
| 2023 | General | $1,985 | 3 | |
| 2022 | General | $100 | 1 | |
| 2021 | General | $59 | 3 | |
| 2020 | General | $213 | 7 | |
| 2020 | Research | $2,194 | 2 | |
| 2019 | General | $624 | 21 |
Beside peers
- Thomas Lovely
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Thomas Lovely were reported at $6,013. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Thomas Lovely | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $624 | $582 | $138–$3,006 | $163 |
| 2020 | $213 | $294 | $76–$2,174 | $114 |
| 2021 | $59 | $387 | $105–$2,432 | $132 |
| 2022 | $100 | $542 | $139–$2,989 | $149 |
| 2023 | $1,985 | $534 | $145–$2,697 | $160 |
| 2024 | $2,113 | $574 | $155–$3,046 | $164 |
| 2025 | $6,013 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
50 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in New York
Ryan Denhaese
Neurological Surgery · Williamsville, NY
J Mocco
Neurological Surgery · New York, NY
Adnan Siddiqui
Neurological Surgery · Williamsville, NY
Leo Hopkins
Neurological Surgery · Buffalo, NY
Aziz Basem Qandah
Neurological Surgery · New Hartford, NY
Alejandro Berenstein
Neurological Surgery · New York, NY
Related records
Neurological Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.